Medication underuse in real-life practice: the impact of galcanezumab towards achieving very low frequency episodic migraine in a southeast Asian middle-income nation
Abstract Background Migraine progression, particularly from episodic to chronic migraine (CM), increases disease burden and healthcare costs. Understanding the new concept of “Medication Underuse Headache” should encourage the health care provider to consider early intervention with calcitonin gene-...
Saved in:
Main Authors: | Wanakorn Rattanawong, Prakit Anukoolwittaya, Akarin Hiransuthikul, Thanakit Pongpitakmetha, Auranee Trisataya, Sekh Thanprasertsuk, Alan Rapoport |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | The Journal of Headache and Pain |
Subjects: | |
Online Access: | https://doi.org/10.1186/s10194-025-01952-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Shift from chronic to episodic migraine frequency in a long-term phase 3 study of galcanezumab
by: Hans-Christoph Diener, et al.
Published: (2025-02-01) -
Filling the data gap on CGRP mAb therapy in low- to middle-income countries in Southeast Asia: insights from a real-world study in Thailand
by: Prakit Anukoolwittaya, et al.
Published: (2024-09-01) -
Correction: Filling the data gap on CGRP mAb therapy in low- to middle-income countries in Southeast Asia: insights from a real-world study in Thailand
by: Prakit Anukoolwittaya, et al.
Published: (2025-01-01) -
RETRACTED ARTICLE: Serum melatonin levels and in a sample of Iranian patients with migraine
by: Mansoureh Togha, et al.
Published: (2024-10-01) -
Evaluation of pediatric migraine triggers: a single-center study
by: Hey-Joon Son, et al.
Published: (2025-02-01)